Co-Diagnostics, Inc. Releases COVID-19 Test Performance Data: Consistently Demonstrates 100% Sensitivity and 100% Specificity Across Independent Evaluations

Go back to Co-Diagnostics, Inc. Releases COVID-19 Test Performance Data: Consistently Demonstrates 100% Sensitivity and 100% Specificity Across Independent Evaluations
(NASDAQ: CODX) Delayed: 1.51 +0.03 (2.03%)
Previous Close $1.48    52 Week High
Open $1.45    52 Week Low
Day High $1.65    P/E N/A 
Day Low $1.45    EPS
Volume 450,189